Manganese-based Hollow Nanoplatforms for MR Imaging-guided Cancer Therapies

Overview

Journal Biomater Res

Specialty Biomedical Engineering

Date 2022 Jul 6

PMID 35794641

Authors

Shuang Liang

Guangfu Liao

Wenzhen Zhu

Li Zhang

Affiliations

Soon will be listed here.

Abstract

Theranostic nanoplatforms integrating diagnostic and therapeutic functions have received considerable attention in the past decade. Among them, hollow manganese (Mn)-based nanoplatforms are superior since they combine the advantages of hollow structures and the intrinsic theranostic features of Mn. Specifically, the hollow cavity can encapsulate a variety of small-molecule drugs, such as chemotherapeutic agents, photosensitizers and photothermal agents, for chemotherapy, photodynamic therapy (PDT) and photothermal therapy (PTT), respectively. After degradation in the tumor microenvironment (TME), the released Mn is able to act simultaneously as a magnetic resonance (MR) imaging contrast agent (CA) and as a Fenton-like agent for chemodynamic therapy (CDT). More importantly, synergistic treatment outcomes can be realized by reasonable and optimized design of the hollow nanosystems. This review summarizes various Mn-based hollow nanoplatforms, including hollow MnO, hollow matrix-supported MnO, hollow Mn-doped nanoparticles, hollow Mn complex-based nanoparticles, hollow Mn-cobalt (Co)-based nanoparticles, and hollow Mn-iron (Fe)-based nanoparticles, for MR imaging-guided cancer therapies. Finally, we discuss the potential obstacles and perspectives of these hollow Mn-based nanotheranostics for translational applications. Mn-based hollow nanoplatforms such as hollow MnO nanoparticles, hollow matrix-supported MnO nanoparticles, Mn-doped hollow nanoparticles, Mn complex-based hollow nanoparticles, hollow Mn-Co-based nanoparticles and hollow Mn-Fe-based nanoparticles show great promise in cancer theranostics.

Citing Articles

Emerging nitric oxide gas-assisted cancer photothermal treatment.

Liang S, Liu Y, Zhu H, Liao G, Zhu W, Zhang L Exploration (Beijing). 2024; 4(6):20230163.

PMID: 39713202 PMC: 11655315. DOI: 10.1002/EXP.20230163.

Advances in hybridized nanoarchitectures for improved oro-dental health.

Guo J, Wang P, Li Y, Liu Y, Ye Y, Chen Y J Nanobiotechnology. 2024; 22(1):469.

PMID: 39113060 PMC: 11305065. DOI: 10.1186/s12951-024-02680-5.

Near Infrared Biomimetic Hybrid Magnetic Nanocarrier for MRI-Guided Thermal Therapy.

Rocha J, Krause R, Ribeiro C, Oliveira N, Ribeiro de Sousa L, Leandro Santos Jr J ACS Appl Mater Interfaces. 2024; 17(9):13094-13110.

PMID: 38973727 PMC: 11891835. DOI: 10.1021/acsami.4c03434.

Advancing cancer theranostics through biomimetics: A comprehensive review.

Anitha K, Chenchula S, Surendran V, Shvetank B, Ravula P, Milan R Heliyon. 2024; 10(6):e27692.

PMID: 38496894 PMC: 10944277. DOI: 10.1016/j.heliyon.2024.e27692.

A multifunctional biomimetic nanoplatform for image-guideded photothermal-ferroptotic synergistic osteosarcoma therapy.

Liu Y, Dong S, Hu W, Chen Q, Zhang S, Song K Bioact Mater. 2024; 36:157-167.

PMID: 38463554 PMC: 10924166. DOI: 10.1016/j.bioactmat.2024.02.007.

References

Jing L, Liang X, Li X, Lin L, Yang Y, Yue X . Mn-porphyrin conjugated Au nanoshells encapsulating doxorubicin for potential magnetic resonance imaging and light triggered synergistic therapy of cancer. Theranostics. 2014; 4(9):858-71. PMC: 4107288. DOI: 10.7150/thno.8818. View

Xu W, Qing X, Liu S, Yang D, Dong X, Zhang Y . Hollow Mesoporous Manganese Oxides: Application in Cancer Diagnosis and Therapy. Small. 2022; 18(15):e2106511. DOI: 10.1002/smll.202106511. View

Little R, Jamin Y, Boult J, Naish J, Watson Y, Cheung S . Mapping Hypoxia in Renal Carcinoma with Oxygen-enhanced MRI: Comparison with Intrinsic Susceptibility MRI and Pathology. Radiology. 2018; 288(3):739-747. PMC: 6122194. DOI: 10.1148/radiol.2018171531. View

Jiao W, Zhang T, Peng M, Yi J, He Y, Fan H . Design of Magnetic Nanoplatforms for Cancer Theranostics. Biosensors (Basel). 2022; 12(1). PMC: 8774163. DOI: 10.3390/bios12010038. View

Meng X, Zhou K, Qian Y, Liu H, Wang X, Lin Y . Hollow Cuprous Oxide@Nitrogen-Doped Carbon Nanocapsules for Cascade Chemodynamic Therapy. Small. 2022; 18(15):e2107422. DOI: 10.1002/smll.202107422. View

Xu J, Shamul J, Kwizera E, He X . Recent Advancements in Mitochondria-Targeted Nanoparticle Drug Delivery for Cancer Therapy. Nanomaterials (Basel). 2022; 12(5). PMC: 8911864. DOI: 10.3390/nano12050743. View

Pan X, Wang W, Huang Z, Liu S, Guo J, Zhang F . MOF-Derived Double-Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging-Guided Sonodynamic Therapy. Angew Chem Int Ed Engl. 2020; 59(32):13557-13561. DOI: 10.1002/anie.202004894. View

Chen J, Zhang W, Zhang M, Guo Z, Wang H, He M . Mn(II) mediated degradation of artemisinin based on Fe3O4@MnSiO3-FA nanospheres for cancer therapy in vivo. Nanoscale. 2015; 7(29):12542-51. DOI: 10.1039/c5nr02402a. View

Chen W, Luo G, Zhang X . Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials. Adv Mater. 2018; 31(3):e1802725. DOI: 10.1002/adma.201802725. View

10.

Yang Z, Zhang L, Wei J, Li R, Xu Q, Hu H . Tumor acidity-activatable photothermal/Fenton nanoagent for synergistic therapy. J Colloid Interface Sci. 2022; 612:355-366. DOI: 10.1016/j.jcis.2021.12.134. View

11.

Tang Q, Yu Y, Zhang H, Wang Y, Liu J, Yang S . NIR light-controlled mitochondria-targeted delivery of carbon monoxide combined with histone deacetylase inhibition for synergistic anticancer therapy. J Inorg Biochem. 2021; 226:111656. DOI: 10.1016/j.jinorgbio.2021.111656. View

12.

Dong Z, Feng L, Hao Y, Chen M, Gao M, Chao Y . Synthesis of Hollow Biomineralized CaCO-Polydopamine Nanoparticles for Multimodal Imaging-Guided Cancer Photodynamic Therapy with Reduced Skin Photosensitivity. J Am Chem Soc. 2018; 140(6):2165-2178. DOI: 10.1021/jacs.7b11036. View

13.

Chen Y, Gao M, Zhang L, Ha E, Hu X, Zou R . Tumor Microenvironment Responsive Biodegradable Fe-Doped MoO Nanowires for Magnetic Resonance Imaging Guided Photothermal-Enhanced Chemodynamic Synergistic Antitumor Therapy. Adv Healthc Mater. 2020; 10(6):e2001665. DOI: 10.1002/adhm.202001665. View

14.

Lin L, Wang J, Song J, Liu Y, Zhu G, Dai Y . Cooperation of endogenous and exogenous reactive oxygen species induced by zinc peroxide nanoparticles to enhance oxidative stress-based cancer therapy. Theranostics. 2019; 9(24):7200-7209. PMC: 6831298. DOI: 10.7150/thno.39831. View

15.

Zhang R, Zeng Q, Li X, Xing D, Zhang T . Versatile gadolinium(III)-phthalocyaninate photoagent for MR/PA imaging-guided parallel photocavitation and photodynamic oxidation at single-laser irradiation. Biomaterials. 2021; 275:120993. DOI: 10.1016/j.biomaterials.2021.120993. View

16.

Lin K, Gan Y, Zhu P, Li S, Lin C, Yu S . Hollow mesoporous polydopamine nanospheres: synthesis, biocompatibility and drug delivery. Nanotechnology. 2021; 32(28). DOI: 10.1088/1361-6528/abf4a9. View

17.

Tang T, Chang B, Zhang M, Sun T . Nanoprobe-mediated precise imaging and therapy of glioma. Nanoscale Horiz. 2021; 6(8):634-650. DOI: 10.1039/d1nh00182e. View

18.

Wang J, Liu L, You Q, Song Y, Sun Q, Wang Y . All-in-One Theranostic Nanoplatform Based on Hollow MoS for Photothermally-maneuvered Oxygen Self-enriched Photodynamic Therapy. Theranostics. 2018; 8(4):955-971. PMC: 5817104. DOI: 10.7150/thno.22325. View

19.

Shiraishi K, Kawano K, Maitani Y, Yokoyama M . Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics. J Control Release. 2010; 148(2):160-7. DOI: 10.1016/j.jconrel.2010.08.018. View

20.

Deng Z, Zhen Z, Hu X, Wu S, Xu Z, Chu P . Hollow chitosan-silica nanospheres as pH-sensitive targeted delivery carriers in breast cancer therapy. Biomaterials. 2011; 32(21):4976-86. DOI: 10.1016/j.biomaterials.2011.03.050. View